Sorrento Therapeutics Inc. (SRNE): Wildcat Capital Management Growing Impatient With Lack of Disclosure, Repeats Demands

Page 13 of 14

Page 13 of 14 – SEC Filing

INDEX TO EXHIBITS

1. Agreement of Joint Filing as required by Rule 13d-1(k)(1) under the Act.(1)
2. Demand for Inspection of Books and Records, dated April 11, 2016.(2)
3. Verified Complaint for Inspection of Books and Records filed in the Court of Chancery of the State of Delaware on April 25,
2016.(3)
4. Letter to the Board of Directors of the Issuer, dated May 5, 2016.(4)
5. Letter to the Board of Directors of the Issuer, dated May 10, 2016.(5)
6. Verified Derivative Complaint filed in the Court of Chancery of the State of Delaware on May 13, 2016.(6)
7. Plaintiff’s Motion for Temporary Restraining Order filed in the Court of Chancery of the State of Delaware on May 13, 2016.(7)
8. Plaintiff’s Brief in Support of Motion for Temporary Restraining Order, to Expedite the Proceedings, and to Schedule
a Preliminary Injunction Hearing, filed in the Court of Chancery of the State of Delaware on May 13, 2016.(8)
9. Letter to the Board of Directors of the Issuer, dated June 1, 2016.

_________________

(1) Incorporated
herein by reference to the Agreement of Joint Filing by and among Wildcat Capital Management, LLC (“Wildcat”),
Wildcat – Liquid Alpha, LLC (“WLA”), Infinity Q Capital Management, LLC (“IQCM”), Infinity
Q Management Equity, LLC (“IQME”), Infinity Q Diversified Alpha Fund (“IQDA”), Bonderman
Family Limited Partnership (“BFLP”), Leonard A. Potter and James Velissaris, dated as of April 18, 2016, which
was previously filed with the SEC as Exhibit 1 to Schedule 13G filed by Wildcat Capital Management, LLC, Wildcat – Liquid
Alpha, LLC, Infinity Q Capital Management, LLC, Infinity Q Management Equity, LLC, Infinity Q Diversified Alpha Fund, Bonderman
Family Limited Partnership, Leonard A. Potter and James Velissaris, on April 18, 2016.

(2) Incorporated
herein by reference to Demand for Inspection of Books and Records, dated April 11, 2016, which was previously filed with the SEC
as Exhibit 2 to Schedule 13D filed by Wildcat, WLA, IQCM, IQME, IQDA, BFLP, Leonard A. Potter and James Velissaris, on April 18,
2016.

(3) Incorporated
herein by reference to Verified Complaint for Inspection of Books and Records filed in the Court of Chancery of the State of Delaware
on April 25, 2016, which was previously filed with the SEC as Exhibit 3 to Amendment No. 1 to Schedule 13D filed by Wildcat, WLA,
IQCM, IQME, IQDA, BFLP, Leonard A. Potter and James Velissaris, on April 26, 2016.

Page 13 of 14 Pages

Follow Sorrento Therapeutics Inc. (NASDAQ:SRNEQ)

Page 13 of 14